Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Bhaswati Sarcar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-7601-6751; OpenAlex author ID A5020843285. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acssensors.5c04552↗
  2. A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles. Co-author DOI 10.1016/j.mcpro.2022.100438↗
  3. Hypoxia-Induced Autophagy Degrades Stromal Lumican into Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma: A Mini-Review. Co-author DOI 10.29245/2578-2967/2019/1.1165↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason B. Fleming · 3 shared papers, 2019–2026 · strength 0.61
  2. Jennifer B. Permuth · 2 shared papers, 2022–2026 · strength 0.45
  3. Andrew A. Beharry · 1 shared paper, 2026 · strength 0.30
  4. Karishma Kailass · 1 shared paper, 2026 · strength 0.30
  5. Xinqun Li · 1 shared paper, 2019 · strength 0.16
  6. Daniel K. Jeong · 1 shared paper, 2022 · strength 0.15
  7. Paul A. Stewart · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.